电针丰隆穴调节血脂的多中心随机对照研究

目的:观察电针丰隆穴调节血脂的临床疗效.方法:将204例高脂血症患者随机分为丰隆组和血脂康组,每组102例.丰隆组取丰隆穴,针刺得气后,接LH 202 H型韩氏(HANS)穴位神经刺激仪,电针参数为:高甘油三酯血症选取频率AM 50 Hz、强度1 mA,留针20 min,每周2次;高胆固醇血症选取频率AM 100 Hz、强度1 mA,留针30 min,隔日1次,每周3次;低密度脂蛋白偏高者,电针强度以舒适耐受为度,余同高胆固醇血症;混合型者选相应方案交替使用.血脂康组口服血脂康胶囊,每次2粒,每日2次,治疗11周.结果:丰隆组总有效率为83.0%,血脂康组为85.9%,组间差异无统计学意义(P＞0.05).电针丰隆穴调节血脂的作用与血脂康比较,差异无统计学意义(均P＞0.05).治疗结束后1个月随访显示,血脂总胆固醇(CHO)、甘油三酯(TG)、低密度脂蛋白(LDL-C)呈继续下降趋势,高密度脂蛋白(HDL-C)呈继续上升趋势,其中电针丰隆穴后TG的下降有统计学意义(P＜0.05),两组复发率均为0.结论:电针丰隆穴可有效调节血脂,而且有较好的后效应,可以替代降脂药物成为临床调节血脂的安全有效方法.

Multi-central randomized controlled study on electroacupuncture at Fenglong(ST 40)for regulating blood lipids

Objective To investigate the clinical effects of electroacupuncture (EA) at Fenglong (ST 40) on blood lipids. Methods Two hundred and four patients of hyperlipidemia were randomly divided into a Fenglong group and a Xuezhikang group, 102 cases in each group. The patients in the Fenglong group were treated with electroacupuncture at Fenglong (ST 40). After arrival of qi, the needles were connected with acupoint nerve stimulator (LH 202 H type, HANS). The primary parameters of EA: for high triglycerides (TG) type, AM 50 Hz, intensity 1 mA, needle-retained time 20 min, twice per week; for high cholesterol (CHO) type, AM 100 Hz, intensity 1 mA, needle-retained time 30 min, thrice per week; for high low-density-lipoprotein (LDL-C) type, the same parameters as the high CHO type except the tolerable and comfortable intensity; for the mixing type, corresponding methods were alternatively used. The patients in the Xuezhikang group received Xuezhikang capsule orally, 2 capsules each time and twice daily, for total 11 weeks. Results The total effective rates of the Fenglong group and the Xuezhikang group were 83.0% and 85.9%, respectively, with no significant difference between the two groups (P>0. 05), and there was no significant differences in the function of regulating blood lipids between the two groups (all P>0. 05). After one month follow-up survey, the total CHO, TG and LDL-C decreased and high-densi-ty-lipoprotein (HDL-C) increased, of which there was a significant difference in TG reduction (P<0. 05). There were no relapses in both groups. Conclusion EA at Fenglong (ST 40) can effectively regulate blood lipids with a better after-effect, which can be applied as a safe and effective method to replace medication for regulating blood lipids.